HPV Vaccine Work Group

The HPV vaccine has a rich history of advancements, leading to a potential shift to a one-dose schedule. Emerging evidence suggests that a single dose provides solid protection against cervical cancer, prompting consideration by organizations like the WHO. While further studies are ongoing, countries like Australia are already implementing this approach. The future of HPV vaccination looks promising.